ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelleher, P.
Right arrow Articles by Levin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelleher, P.
Right arrow Articles by Levin, M.
Eur Respir J 2006; 27:1307-1310
Copyright ©ERS Journals Ltd 2006

Interferon-{gamma} therapy in two patients with progressive chronic pulmonary aspergillosis

P. Kelleher1,2, A. Goodsall3, A. Mulgirigama4, H. Kunst2, D. C. Henderson1, R. Wilson2, A. Newman-Taylor4 and M. Levin3

1 Dept of Immunology, Imperial College, Chelsea & Westminster Hospital, 2 Host Defence Unit, Royal Brompton Hospital, 3 Dept of Academic Paediatrics, Wright Fleming Building, Imperial College, St Mary's Hospital, and 4 Dept of Respiratory Medicine and the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, UK.

CORRESPONDENCE: P. Kelleher, Dept of Immunology, Imperial College, Chelsea & Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK. Fax: 44 20874667559. E-mail: p.kelleher{at}imperial.ac.uk

Keywords: Chronic pulmonary Aspergillus infection, interferon-{gamma} therapy

Received: February 24, 2005
Accepted October 13, 2005

Infection by Aspergillus species causes a wide spectrum of pulmonary disease in humans.

In two patients with semi-invasive Aspergillus-induced lung disease, significantly reduced levels of interferon-{gamma} secretion by peripheral blood mononuclear cells were found after in vitro stimulation with the T-cell mitogen phytohaemagglutinin. Despite anti-fungal therapy, both patients exhibited progressive disease, and adjunctive interferon-{gamma} therapy was associated with significant clinical improvement.

The data suggest that impaired production of interferon-{gamma} can be seen in patients with chronic pulmonary aspergillosis. Adjunctive cytokine therapy with interferon-{gamma} may be useful in patients with progressive disease despite adequate anti-fungal therapy.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. J. Park, M. A. Hughes, M. Burdick, R. M. Strieter, and B. Mehrad
Early NK Cell-Derived IFN-{gamma} Is Essential to Host Defense in Neutropenic Invasive Aspergillosis
J. Immunol., April 1, 2009; 182(7): 4306 - 4312.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.